Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety Study of Adjuvant Vaccine to Treat Melanoma Patients

This study has been completed.
Sponsor:
Collaborators:
Ludwig Institute for Cancer Research
Oncovir, Inc.
Cancer Research Institute, New York City
Information provided by (Responsible Party):
Nina Bhardwaj, Mount Sinai School of Medicine
ClinicalTrials.gov Identifier:
NCT01079741
First received: March 2, 2010
Last updated: January 6, 2015
Last verified: December 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2013
  Primary Completion Date: March 2013 (Final data collection date for primary outcome measure)